| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Sep 3, 2025 | Adaptimmune Therapeutics PLC | CFO | Sell | 27.5 | -96,000 | -100.00% | ✗ | $950.4 |
| May 20, 2022 | May 23, 2022 | Adaptimmune Therapeutics PLC | CFO | Buy | 91.3 | +39,000 | 68.42% | ✗ | $11.3K |
| Dec 14, 2020 | Dec 16, 2020 | Adaptimmune Therapeutics PLC | CFO | Buy | 91.3 | +24,000 | 72.73% | ✗ | $16.6K |
| Jun 29, 2020 | Jun 30, 2020 | Adaptimmune Therapeutics PLC | CFO | Buy | 95.0 | +33,000 | 100.00% | ✗ | $53.5K |